Zimmer to record 2013 pre-tax charges of $120M-$130M The Company expects to record 2013 pre-tax charges of $120M-$130M as details of the various programs are finalized and implemented. The Company also expects to incur an additional $5M-$15M for certain acquisition and integration costs connected with the acquisitions of Dornoch Medical Systems, Inc., Exopro and third party distributors around the world.
BIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).